Showing results (281-290 of 482) with videos related to

Sort By:
Pageof 49
The Journal of Allergy and Clinical Immunology|June 1, 1985
Acquired deficiency of the inhibitor of the first component of complement: report of five additional cases with commentary on the syndromeA L Sheffer, K F Austen, F S Rosen, et al.
International Journal of Peptide and Protein Research|April 1, 1985
Conformation of the eosinophil chemotactic tetrapeptides and analogues in dimethyl sulfoxide. 1H n.m.r. studiesG R Beilharz, J A Smith, K F Austen, et al.
The Journal of Biological Chemistry|February 25, 1991
Cloning of the cDNA and gene of mouse mast cell protease-6. Transcription by progenitor mast cells and mast cells of the connective tissue subclassD S Reynolds, D S Gurley, K F Austen, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1976
Control of the amplification convertase of complement by the plasma protein beta1HJ M Weiler, M R Daha, K F Austen, et al.
Clinical and Experimental Immunology|April 1, 1978
Cutaneous necrotizing venulitis: a sequential analysis of the morphological alterations occurring after mast cell degranulation in a patient with a unique syndromeN A Soter, M C Mihm, H F Dvorak, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1983
Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factorA Nicholson-Weller, J P March, S I Rosenfeld, et al.
The New England Journal of Medicine|March 13, 1980
Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticariaN A Soter, S I Wasserman, K F Austen, et al.
The Journal of Experimental Medicine|February 1, 1978
Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparinJ M Weiler, R W Yurt, D T Fearon, et al.
The Journal of Biological Chemistry|February 5, 1986
Inhibition of homogeneous human eosinophil arylsulfatase B by sulfidopeptide leukotrienesP F Weller, E J Corey, K F Austen, et al.
The Journal of Experimental Medicine|November 1, 1979
Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3bM D Kazatchkine, D T Fearon, J E Silbert, et al.
Pageof 49